Anmelden

Hua Zhou

ProMab Biotechnologies. Inc

BIOGRAPHY

Hua Zhou has not added Biography.

If you are Hua Zhou and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.

Cancers Oct, 2017 | Pubmed ID: 29065481

CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth.

Cancers Sep, 2018 | Pubmed ID: 30208593

FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells and .

Frontiers in bioscience (Landmark edition) 06, 2017 | Pubmed ID: 28410137

GITR domain inside CAR co-stimulates activity of CAR-T cells against cancer.

Frontiers in bioscience (Landmark edition) 06, 2018 | Pubmed ID: 29772559

Generation of CAR-T Cells for Cancer Immunotherapy.

Methods in molecular biology (Clifton, N.J.) , 2019 | Pubmed ID: 30465215

Hypoxia Selectively Impairs CAR-T Cells In Vitro.

Cancers Apr, 2019 | Pubmed ID: 31052261

Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells and .

Frontiers in bioscience (Landmark edition) Jan, 2020 | Pubmed ID: 31585889

DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers.

Cancers Dec, 2019 | Pubmed ID: 31878090

PLAP -CAR T cells mediate high specific cytotoxicity against colon cancer cells.

Frontiers in bioscience (Landmark edition) Jun, 2020 | Pubmed ID: 32472757

Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma.

Cancers Feb, 2021 | Pubmed ID: 33652767

Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma.

Biomedicines Oct, 2021 | Pubmed ID: 34680541

mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth.

Cancers May, 2023 | Pubmed ID: 37345198

CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.

International journal of molecular sciences Aug, 2023 | Pubmed ID: 37686170

HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth.

Vaccines Jul, 2024 | Pubmed ID: 39066446

INSTITUTIONS

ProMab Biotechnologies. Inc

ProMab Biotechnologies

JOVE ARTICLES

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Biao Xi¹,

Robert Berahovich²,

Hua Zhou²,

Shirley Xu²,

Yuehua Wei²,

Jasper Guan²,

Hizkia Harto²,

Jian Guan²,

Lijun Wu²,

David Santa Ana^1,3,

Fabio Cerignoil¹,

Brandon Lamarche¹,

Yama A. Abassi¹,

Vita Golubovskaya²

¹, ACEA Biosciences, Inc,

², ProMab Biotechnologies. Inc,

³, ACEA Therapeutics

Immunology and Infection

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Liang Hu¹,

Robert Berahovich¹,

Yanwei Huang¹,

Shiming Zhang¹,

Jinying Sun¹,

Xianghong Liu¹,

Hua Zhou¹,

Shirley Xu¹,

Haoqi Li¹,

Vita Golubovskaya¹,

Lijun Wu¹

¹, ProMab Biotechnologies

Cancer Research

Datenschutz

Nutzungsbedingungen

Richtlinien

Kontakt

BIBLIOTHEKS-EMPFEHLUNG

JoVE-Newsletter

Forschung

JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv

Lehre

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Faculty Site

Autoren

Übersicht
Veröffentlichungsprozess
Redaktionsausschuss
Umfang und Richtlinien
Peer Review
Häufig gestellte Fragen
Einreichen

Bibliothekare

Übersicht
Erfahrungsberichte
Lizenzen
Zugang
Ressourcen
Bibliotheksbeirat
Häufig gestellte Fragen

ÜBER JoVE

Übersicht
Geschäftsführung
Blog
JoVE Help Center